Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Hobbs999on Aug 24, 2021 9:31am
119 Views
Post# 33754009

RE:RE:RE:RE:CEO's latest buy

RE:RE:RE:RE:CEO's latest buyMy take: sp is depressed for good reason and many got disapointed and sold leading to many others doing the same. Add to that lack of interest/distrust of management so no buying.
BUT
keep in mind that the same is true for many other juniors in the same field in the last 6 months
Check the peers: they have all gone down lately.
Sector trends always impacts individual stocks.
check spectra medical T.EDT with 84 million market cap on 2 million revenue down more than 50% from high
Or Sqd V.SQD with a 65 million market cap on 1 million down 65%.
So the sector is pretty bad currently.
Most of the peers have no revenue and we should conservatively have around 15 million next year
That should give us a market cap of at least 50 million.
So your choice is to stick here and hope to recoup you losses or risk loosing more in overvalued popular stocks.
But yes we can go lower but at some point its gonna go back up, its done it in early 2019, april  2020, earlier this year.
Just hold and sell when the time is right.
good luck
<< Previous
Bullboard Posts
Next >>